Here are relevant reports on : rare-disease-treatment-market
-
Asia Pacific Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs), and Country - Forecast to 2031
The Asia Pacific periodontal disease treatment market is projected to reach USD 0.91 billion by 2031 from USD 0.64 billion in 2026, at a CAGR of 6.0%. The Key Players include DENTSPLY SIRONA Inc. (US), Envista (US), A-dec Inc. (US), J. MORITA CORP. (Japan), Institut Straumann AG (Switzerland), BEGO GmbH & Co. KG (Germany), Ultradent Products, Inc. (US), Yoshida Dental MFG. Co., Ltd. (Japan), Nakanishi Inc. (Japan), Geistlich Pharma AG (Switzerland), RTI Surgical (US), and Keystone Dental Group (US)
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs), and Region - Global Forecast to 2030
The global periodontal disease treatment market, valued at US$2.44 billion in 2023, stood at US$2.58 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2030, culminating in a forecasted valuation of US$3.63 billion by the end of the period. The growth of this market can be attributed to the expansion of pharmaceutical manufacturing facilities, increased demand for biopharmaceuticals, rapid growth of contract manufacturing companies to drive market.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020
The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020. Factors such as rising preference of NGS over other platforms; rapid and cost-efficient sequencing; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities are expected to drive market growth. However, high dependence on grants for R&D, lack of analytics, and stringent reimbursement policies are likely to restrict the growth of this market to a certain extent.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
Nuclear Medicine Software Market by Software (Image Management, Workflow, PACS, Dosimetry, Treatment, AI/Analytics), Application (Diagnosis, Treatment, Theranostics, Research), Disease (Onco, Neuro, Cardio), End User & Region - Global Forecast to 2030
The global nuclear medicine software market, valued at US$887.5million in 2024, stood at US$970.0 million in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of US$1,491.5 million by the end of the period. This growth is mainly driven by the increasing demand for early and accurate diagnostics, as precision imaging is essential for treatment planning.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Stomach Cancer Treatment Market by Treatment, Type (Chemotherapy, Immunotherapy), Disease Indication (Gastric Cancer), Route of Administration, Drug Class (PD-1/PD-L1 inhibitors, HER2 antagonists), Distribution Channel - Global Forecast to 2027
The global stomach cancer treatment market is projected to reach USD 8 billion by 2027 from USD 4 Billion in 2022, at a CAGR of 14% during the forecast period
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Parkinson's Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) - Global Forecast to 2022
The Parkinson's disease treatment market is expected to reach USD 5.69 Billion by 2022 from USD 4.24 Billion in 2017, at a CAGR of 6.1%. The market is being driven by the growth in aging population and the associated increase in the prevalence of Parkinson’s disease and government funding for research. Some of the major players operating in the Parkinson’s disease treatment market include Teva (Israel), Novartis AG (Switzerland), GSK (UK), AbbVie (US), Merck (US), Boehringer Ingelheim (Germany), Impax Laboratories (US), Lundbeck (Denmark), Sun Pharma (India), Wockhardt (India), UCB (Belgium), Valeant Pharmaceuticals (Canada), and Acadia (US).
- Published: October 2017
- Price: $ 4950
- TOC Available:
-
Overactive Bladder Treatment Market Size by Drug type (Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) & Region - Global Forecast to 2027
The size of global overactive bladder treatment market in terms of revenue was estimated to be worth USD 3.5 billion in 2022 and is poised to reach USD 4.2 billion by 2027, growing at a CAGR of 3.6% from 2022 to 2027. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: July 2022
- Price: $ 7150
- TOC Available:
-
Rare Earth Industry Challenges and Outlook 2011-2020
Rare Earth elements (REE) are 17 different rare earth elements which are used extensively in a wide variety of applications to make technologies lighter, stronger, more efficient, and easier to use. REEs are used to make super strong permanent magnets that increase the efficiency of wind generators while significantly reducing their weight. They are used extensively in electric vehicles to increase battery capacity and reduce weight, in medicine for small, portable X-ray devices as well as lasers that can treat glaucoma and other conditions. The United States produced most of the world’s REE up until about 1985, at which time China began to become a major supplier. Today, China produces about 97% of the world’s rare earths. Problems stemming from this (virtually) single source include supply constraints, reduced shipments and export quotas, environmental problems, and rising prices. There is huge worry from many industry players of potential supply crunch of REE from China.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Produced Water Treatment Market by Application (Onshore, Offshore), Source (Conventional, Unconventional), Treatment (Primary treatment, Secondary treatment, Tertiary treatment) and Region - Global Forecast to 2029
The produced water treatment market is projected to reach USD 13.4 billion by 2029, at a CAGR of 4.7% during the forecast period. Some of the major players in the produced water treatment market are SLB (US), Baker Hughes Company (US), Siemens Energy (Germany), Veolia Environnement SA (France), TechnipFMC (UK). The major strategies adopted by these players include sales contracts, product launches, investments, collaborations, partnerships, and expansions.
- Published: June 2024
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
